Vir Biotechnology, Inc.
CAGE Code: 80UV6
NCAGE Code: 80UV6
Status: Active
Type: Commercial Supplier
Summary
Vir Biotechnology, Inc. is an Active Commercial Supplier with the Cage Code 80UV6.
Address
1800 Owens St Ste 900
San Francisco CA 94158-2388
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Business Development Inc Advanced Product Exchange, Inc. Tetra Tech Inc Atlas Heating And Vent Co Ltd Teknowlogy Education Centers San Sumeria Inc Gasair Associates Grammarly, Inc. Aquatecs Intl Lazarus Data Recovery S And C Ford Blue Star North America Ltd Naissance Av Inc Lee And Kay Corp Dmc Communications, Inc. Square D Co Western Div Blaisdell Frances Western Piping And Engineering Co Wired Co Wired Ventures Ltd
Frequently Asked Questions (FAQ) for CAGE 80UV6
- What is CAGE Code 80UV6?
- 80UV6 is the unique identifier used by NATO Organizations to reference the physical entity known as Vir Biotechnology, Inc. located at 1800 Owens St Ste 900, San Francisco CA 94158-2388, United States.
- Who is CAGE Code 80UV6?
- 80UV6 refers to Vir Biotechnology, Inc. located at 1800 Owens St Ste 900, San Francisco CA 94158-2388, United States.
- Where is CAGE Code 80UV6 Located?
- CAGE Code 80UV6 is located in San Francisco, CA, USA.
Contracting History for CAGE 80UV6 Most Recent 25 Records
- 75A50122C00081
- Vir Biotechnology - Ota For Pre-Exposure Prophylactic Monoclonal Antibodies For The Prevention Of Influenza Illness And Medical Countermeasures For Other Emerging Pathogens Of Pandemic Potential
- 28 Sep 2022
- Vir Biotechnology - Ota For Pre-Exposure Prophylactic Monoclonal Antibodies For The Prevention Of Influenza Illness And Medical Countermeasures For Other Emerging Pathogens Of Pandemic Potential
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $55,000,000.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00081
- Vir Biotechnology - Ota For Pre-Exposure Prophylactic Monoclonal Antibodies For The Prevention Of Influenza Illness And Medical Countermeasures For Other Emerging Pathogens Of Pandemic Potential
- 28 Sep 2023
- Vir Biotechnology - Ota For Pre-Exposure Prophylactic Monoclonal Antibodies For The Prevention Of Influenza Illness And Medical Countermeasures For Other Emerging Pathogens Of Pandemic Potential
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $116,300,401.00
- Department Of Health And Human Services (Hhs)